3rd Annual Imaging Mass Cytometry User Group

October 3–4, 2019 | Renaissance Zurich Tower Hotel, Zurich, Switzerland

Save the date and join us in Zurich!

Don’t miss this! Mark your calendar for Thursday, October 3, and Friday, October 4. Please plan to join us this fall in Zurich, Switzerland, for the 3rd Annual Imaging Mass Cytometry™ User Group Meeting (IMC™ UGM). The growing IMC community will gather at the Renaissance Zurich Tower Hotel to share experiences, present IMC research, discuss a range of important topics and pursue networking and collaboration opportunities.

See a summary of the 2018 IMC UGM.

3rd Annual Imaging Mass Cytometry User Group Meeting

Thursday, October 3, and Friday, October 4, 2019
Renaissance Zurich Tower Hotel
Zurich, Switzerland

Reserve your spot

Registration is free, but space is limited. Registration is limited to Hyperion™ Imaging System owners and users and those who are considering use or purchase of a system.


See the final full agenda below!

Spend two days learning about how researchers in this community are using the Hyperion Imaging System to get biologically relevant results that advance their understanding of human health and disease. Join top translational and pharmaceutical research scientists, pathologists and service providers who share their data and their stories, provide educational outlooks and help lead panel discussions.

The first day will be followed by an evening reception at a fabulous local Zurich venue. There will also be breaks and extended lunch periods where you can network, and tables set up where you can discuss data analysis solutions with various providers and application scientists.

Thursday, October 3

Time Presentation Title Speaker Institution
7:00–7:45 Light breakfast and registration
7:50–8:00 Welcome Address Chris Linthwaite Fluidigm
8:00–8:10 Introductory Comments Mina Lakshman, PhD Fluidigm
8:10–8:50 Imaging Mass Cytometry: A Powerful Tool for Precision Medicine Bernd Bodenmiller, PhD University of Zurich
8:50–9:15 Understanding the Immune Composition and Therapeutic Implications in Human Lung Cancer Using Imaging Mass Cytometry and Spatial Analysis Kurt Schalper, MD, PhD Yale School of Medicine
9:15–9:40 Imaging Tissue-Resident Deregulated Immune Responses in Immune-Mediated Inflammatory Disorders Frits Koning, PhD Leiden University Medical Center
9:40–10:10 Networking Lounge and Break
10:10–10:25 Integrating Imaging Mass Cytometry with Complementary Technologies for Greater Insights Mina Lakshman, PhD Fluidigm
10:25–11:05 Multimodal Mass Spec Imaging for a Greater Understanding of Biological Tissues Gregory Hamm, PhD
Stephanie Ling, PhD
11:05–11:30 Playing to the Assay’s Strengths Jared Burks, PhD University of Texas MD Anderson Cancer Center
11:30–11:55 Exploring the Landscapes of Rare Melanoma Subtypes by IMC and Single-Cell RNA-Seq Marie-Laure Yaspo, PhD Max Planck Institute for Molecular Genetics
11:55–1:25 Working Lounge and Lunch
1:25–1:50 The Multicellular Architecture of Breast Cancer Jana Fischer, MSc University of Zurich
1:50–2:15 Highly Multiplexed Single-Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Akil Merchant, MD Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
2:15–2:40 A Pathologist’s-Eye View of Imaging Mass Cytometry Carol Cheung, MD, PhD, JD University Health Network and University of Toronto
2:40–3:05 Deepen Your Understanding: Q&A Session with a Pathologist Carol Cheung, MD, PhD, JD University Health Network and University of Toronto
3:05–3:30 Networking Lounge and Break
3:30–4:45 Panel Discussion: Managing IMC and Collaborating within a Core Lab Setting Jared Burks, PhD
Philip Hobson, PhD
Akil Merchant, MD
Richard Ellis, PhD
Moderator: Andrew Quong, PhD
4:45–4:55 Day 1 Survey
4:55–5:15 Closing Remarks Andrew Quong, PhD Fluidigm

Friday, October 4

7:15–8:00 Light Breakfast and Registration
8:00–8:05 Day 2 Welcome Mina Lakshman, PhD Fluidigm
8:05–8:40 Discovery of Biomarkers for Immunotherapy in Melanoma using Imaging Mass Cytometry David Rimm, MD, PhD Yale School of Medicine
8:40–9:05 Imaging the Compositional, Spatial and Signaling Heterogeneity of Breast Cancer Helen Piwnica-Worms, PhD University of Texas MD Anderson Cancer Center
9:05–9:30 Mapping Dynamic Immunity Across Time, Space, and Disease State Using High-Dimensional Cytometry Technologies and Analytics Tom Ashhurst, BSc University of Sydney
9:30–10:00 Networking Lounge and Break
10:00–10:25 Phenogenomics of Breast Cancer Raza Ali, MD, PhD CRUK Cambridge Institute University of Cambridge
10:25–10:50 Specialized High-Complexity Genomics and Proteomics Services to Support Pharma Drug Discovery and Development Programs Anup Madan, PhD Sirona Dx
10:50–11:15 Multiplex Imaging of Immune Cells in the Multiple Sclerosis Brain Salma Sheikh-Mohamed, MSc University of Toronto

Imaging Mass Cytometry to Characterize Immune Priming in Multiple Myeloma Patients Treated with an Oncolytic Virus
ImaCytE: Visual Exploration of Cellular Microenvironments for Imaging Mass Cytometry Data
Kevin Kelly, MD, PhD

Antonios Somarakis
Nohl Division of Hematology and Center for the study of Blood Diseases University of Southern California
Leiden University Medical Center
11:40–12:50 Networking Lounge and Lunch
12:50–2:05 Panel Discussion: Data Analysis—Choosing and Using the Right Approach Frits Koning, PhD
Trevor McKee, PhD
David Rimm, MD, PhD
Denis Schapiro, PhD

Wendell Smith, PhD
Moderator: Andrew Quong, PhD
Leiden University Medical Center
Princess Margaret Hospital 
Yale School of Medicine
Harvard Medical School and Broad Institute

2:05–2:45 The State of IMC: Work in Progress Dmitry Bandura, PhD Fluidigm
2:45–2:55 Day 2 Survey
2:55 Closing Remarks Andrew Quong, PhD Fluidigm


Register Today

3rd Annual Imaging Mass Cytometry User Group Meeting
Thursday, October 3, 8:00 am–10:00 pm
Friday, October 4, 8:00 am–5:00 pm

* You may withdraw your consent anytime in every email you will receive from us.
To learn more about how we use your information, read our Privacy Policy.

Fluidigm Products are for Research Use Only. Not for use in diagnostic procedures.